BRIEF published on 02/12/2025 at 11:35, 2 months 16 days ago Sensorion to Participate in ARO 48th Annual Midwinter Meeting Sensorion Hearing Loss ARO Meeting GJB2-GT Therapy Biotech Conference
BRIEF published on 02/12/2025 at 11:35, 2 months 16 days ago Sensorion participera à la 48e réunion annuelle de mi-hiver de l'ARO Sensorion Perte Auditive Réunion De L'ARO Thérapie GJB2-GT Conférence Sur Les Biotechnologies
PRESS RELEASE published on 02/12/2025 at 11:30, 2 months 16 days ago Inside Information / Other news releases Sensorion announces participation in ARO 48th Annual Midwinter Meeting with focus on gene therapy for deafness. Details of presentations by Sensorion executives included Gene Therapy Sensorion ARO Meeting Deafness Sensorion Executives
PRESS RELEASE published on 02/12/2025 at 11:30, 2 months 16 days ago Informations privilégiées / Autres communiqués Sensorion participe à la 48ème rencontre annuelle de l'ARO pour présenter ses thérapies novatrices contre la perte auditive Sensorion Perte Auditive Thérapies ARO Rencontre Annuelle
BRIEF published on 12/27/2024 at 07:35, 4 months 4 days ago Sensorion finalise le recrutement pour l'essai de phase 1/2 d'Audiogene Thérapie Génique Sensorion Perte Auditive SENS-501 Essai Audiogene
BRIEF published on 12/27/2024 at 07:35, 4 months 4 days ago Sensorion Completes Enrollment for Audiogene Phase 1/2 Trial Gene Therapy Sensorion Hearing Loss SENS-501 Audiogene Trial
PRESS RELEASE published on 12/27/2024 at 07:30, 4 months 4 days ago Inside Information / Other news releases Sensorion completes enrollment of the first cohort in the Audiogene Phase 1/2 gene therapy clinical trial, targeting infants with hearing loss disorders Gene Therapy Clinical Trial Sensorion Hearing Loss Disorders Audiogene
BRIEF published on 12/18/2024 at 07:35, 4 months 13 days ago Sensorion présente des résultats préliminaires positifs pour le SENS-501 Essai Clinique Thérapie Génique Innovation Biotechnologique SENS-501 Surdité Congénitale
BRIEF published on 12/18/2024 at 07:35, 4 months 13 days ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
PRESS RELEASE published on 12/18/2024 at 07:30, 4 months 13 days ago Informations privilégiées / Autres communiqués Sensorion présente des données positives de l'essai clinique de Phase 1/2 de thérapie génique pour la surdité chez les nourrissons. Nouvelles données encourageantes sur SENS-501. Séminaire en ligne prévu pour 2025 Sécurité Thérapie Génique Phase 1/2 Sensorion Surdité
Published on 05/01/2025 at 02:00, 1 hour 47 minutes ago EQ Inc. Reports Profitable Fourth Quarter and 2024 Year End Financial Results
Published on 05/01/2025 at 00:00, 3 hours 47 minutes ago Tecogen Announces Uplist to NYSE American Stock Exchange
Published on 04/30/2025 at 23:30, 4 hours 17 minutes ago Arras Minerals Announces Voting Results of Annual and Special Meeting of Shareholders
Published on 04/30/2025 at 23:20, 4 hours 27 minutes ago Justera Health Announces Director Resignation and Change to Fiscal Year End
Published on 04/30/2025 at 23:15, 4 hours 32 minutes ago Interactive Strength Inc. (Nasdaq:TRNR) Provides Shareholder Update on 2025 Developments
Published on 04/30/2025 at 23:30, 4 hours 17 minutes ago EEII AG: Ad-Hoc announcement pursuant to Art. 53 Listing Rules: EEII AG 2024 Annual Results
Published on 04/30/2025 at 22:43, 5 hours 3 minutes ago Assemblée générale ordinaire d’Espace Real Estate Holding AG
Published on 04/30/2025 at 21:15, 6 hours 32 minutes ago voxeljet AG announces financial restructuring with StaRUG procedure after general meeting rejects approval of the sale of the business to Anzu
Published on 04/30/2025 at 21:00, 6 hours 47 minutes ago Northern Data Group issues Business and Operational Update
Published on 04/30/2025 at 20:40, 7 hours 6 minutes ago EQS-Adhoc: Northern Data Group Updates 2025 Guidance and Provides New Guidance Framework
Published on 04/30/2025 at 19:14, 8 hours 32 minutes ago Report de la publication des résultats annuels 2024
Published on 04/30/2025 at 19:14, 8 hours 32 minutes ago Solocal - Press Release - Filing of 2024 URD
Published on 04/30/2025 at 19:14, 8 hours 32 minutes ago Solocal - Communiqué de presse - Mise à disposition du DEU 2024
Published on 04/30/2025 at 18:55, 8 hours 51 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 5, 2025
